Probiotics are live bacteria that, when taken in sufficient quantities, contribute to intestinal flora health. For women specifically, the right probiotic strains focus on targeted urogenital health. Bio-K+'s Women's Health capsules contain two clinically studied strains — Lacticaseibacillus rhamnosus GR-1™ and Limosilactobacillus reuteri RC-14™ — which help restore and maintain healthy vaginal flora and support urinary tract microbiota.

Probiotics for women work best when they contain strains specifically studied for women's health. The clinically studied strains Lacticaseibacillus rhamnosus GR-1™ and Limosilactobacillus reuteri RC-14™ help restore and maintain healthy vaginal flora, reduce yeast and bacteria on vaginal surfaces, and support urinary tract microbiota. These strains are backed by 60+ scientific publications, and more than 25 clinical trials conducted over 30+ years of research. The key is choosing a product with strains that are clinically studied and a CFU count that is potency-guaranteed until the expiration date.

Bio-K+'s Women's Health capsules contain two clinically studied strains: Lacticaseibacillus rhamnosus GR-1™ and Limosilactobacillus reuteri RC-14™. These strains are among the most studied vaginal probiotic strains available, backed by 60+ scientific publications. Unlike broad-spectrum probiotic blends, GR-1 and RC-14 have targeted clinical documentation specifically for women's vaginal microbiome health. Each capsule delivers 2 Billion CFU, with potency guaranteed until the expiration date.

Yes. Certain Lactobacillus strains are clinically studied for their documented effects on vaginal flora. L. rhamnosus GR-1™ and L. reuteri RC-14™ — the two strains in Bio-K+'s Women's Health capsules — are specifically studied to help restore and maintain healthy vaginal flora and reduce yeast and bacteria on vaginal surfaces. Together, these actions help support a healthy vaginal flora balance. If you are experiencing vaginal symptoms, consult your healthcare professional for appropriate guidance.